• A case of primary central nervous system lymphoma of the sellar region presented with panhypopituitarism
• A Century of Prolactin: Emerging Perspectives as a Metabolic Regulator
• A review on the pharmacology of cariprazine and its role in the treatment of negative symptoms of schizophrenia
• Acromegaly screening in patients with hyperprolactinemia and pituitary adenoma
• Acute neuroendocrine changes after traumatic brain injury
• Acute retinal pigment epitheliitis during treatment of hyperprolactinaemia
• Adipsic hypernatremia with marked hyperprolactinemia and GH deficiency in a 9-year-old boy
• Aggressive Prolactinoma with Progression to Pituitary Carcinoma: A Case Report
• Amitriptyline-Induced Hyperprolactinemia in a Pediatric Patient
• An Evaluation of a Women's Clinic: The Healthcare and Learning Project of the Functional Unit for Women with Schizophrenia
• An invasive nasopharyngeal carcinoma with extension to the pituitary gland mimicking an invasive pituitary macroadenoma: A case report
• Antipsychotic Use and Risk of Breast Cancer in Women With Severe Mental Illness: Replication of a Nationwide Nested Case-Control Database Study
• Antipsychotics-related hyperprolactinaemia among patients with schizophrenia in Maiduguri
• Assessment of Monitoring and Management Practices of Antipsychotic-Induced Hyperprolactinemia at a Medical City in Riyadh, Saudi Arabia: A Retrospective Cohort Study
• Cardiometabolic effects of hypoprolactinemia
• Case report: Complete restoration of the HPA axis function in Cushing's disease with drug treatment
• Cerebral Computed Tomographic Findings in Schizophrenia: Relationship to Second-Generation Antipsychotics and Hyperprolactinemia
• Characteristics and outcomes of men with erectile dysfunction as the presenting symptom due to a lactotroph adenoma
• Clinical and radiographic characteristics of patients with non-functioning pituitary adenomas categorized according to their serum prolactin concentration: novel predictors of postoperative transient diabetes insipidus following surgery
• Clinical study of Bushen Culuan Formula in treatment of ovulatory disorder infertility caused by hyperprolactinemia
• Clinically active pituitary tumors
• Comparative efficacy of metformin combined with cabergoline versus metformin alone in patients with PCOS and hyperprolactinemia: A systematic review and meta-analysis of randomized controlled trials
• Comparative Study of Extrapyramidal Side Effects, Sexual Dysfunctions and Hyperprolactinaemia Using Typical and Atypical Antipsychotic Medications Among Patients with Schizophrenia in Maiduguri
• Conjugation of sulpiride with a cell penetrating peptide to augment the antidepressant efficacy and reduce serum prolactin levels
• Current and Perspective Approaches to the Treatment of Prolactinomas
• Current Insights in Prolactin Signaling and Ovulatory Function
• Delusional Disorder and Premenstrual Dysphoric Disorder With Antipsychotic-Induced Hyperprolactinemia: A Complex Psychiatric Presentation
• Determining Ideal Management for Patients With Coexisting Prolactinomas and Psychiatric Symptoms: A Systematic Review
• Diagnosis and Dental Management of a Patient With Forbes Albright Syndrome: A Report of a Rare Case
• Diagnosis of hyperprolactinemia in women: A Position Statement from the Brazilian Federation of Gynecology and Obstetrics Associations (Febrasgo) and the Brazilian Society of Endocrinology and Metabolism (SBEM)
• Diagnosis of hypoprolactinemia
• Dopamine Agonists as a Novel "Cure" for Autoimmune Diabetes
• Editorial: Insights in hyperprolactinemia
• Effect of baseline prolactin levels on the pregnancy outcomes after fresh embryo transfer
• Effect of delayed diagnosis on neuroendocrine function in individuals with suprasellar germ cell tumors
• Effect of Hyperprolactinemia on Bone Metabolism: Focusing on Osteopenia/Osteoporosis
• Effectivity of Bromocriptine Administration Towards Prolactin Positive Breast Cancer Receiving Anthracycline-Based Chemotherapy: A Literature Review
• Effects of combined metformin and cabergoline versus metformin alone on ovarian and hormonal activities in Iraqi patients with PCOS and hyperprolactinemia: a randomized clinical trial
• Epidemiology of Endocrine Dysfunctions in Pediatric Patients with Previous Central Nervous System Infection: A Scoping Review of the Literature
• Epigenetic control of adaptive or homeostatic splicing during interval-training activities
• Exploring the association of serum prolactin with serum glucose levels and clinical findings in a cohort of patients with early rheumatoid arthritis
• Expression of concern: "Clinical efficacy of novel unidirectional buccoadhesive vs. vaginoadhesive bromocriptine mesylate discs for treating pathologic hyperprolactinemia"
• Gynura procumbens and selected metabolites: Amelioration of depressive-like behaviors in mice and risperidone-induced hyperprolactinemia in rats
• Hyperhomocysteinemia is associated with the risk of venous thromboembolism in patients with mental illness: a case-control study
• Hyperprolactinemia in Functional Dyspepsia: The Entangled Domperidone Link
• Hyperprolactinemia in women: diagnostic approach
• Hyperprolactinemia in women: treatment
• IL-2 and IL-4 May Reduce the Risk of Pathological Hyperprolactinemia: Genetic Epidemiological Evidence
• Impact of hyperprolactinemia on sexual function
• Influence of CYP2D6 Metabolizer Status on Risperidone and Paliperidone Tolerability in Children and Adolescents
• Lithium Induced Amenorrhea: A First Case Report
• Long-term outcome of surgically treated and conservatively managed Rathke cleft cysts
• Long-term proton pump inhibitors therapy and prevalence of hyperprolactinaemia: A cross-sectional study in outpatient gastroenterology clinics
• Long-term use of clomiphene in male macroprolactinomas with persistent hypogonadism
• Macroprolactin in mothers and their babies: what is its origin?
• Macroprolactin over time: Is there any point in rechecking it in people with a persistently elevated serum prolactin?
• Mechanisms of adverse mammary effect induced by olanzapine and therapeutic interventions in rat model
• Methadone Withdrawal-Related Psychosis in a Patient With Hormone-Dependent Breast Cancer: A Case Report
• Neuregulin 4 (Nrg4) cooperates with melatonin to regulate the PRL expression via ErbB4/Erk signaling pathway as a potential prolactin (PRL) regulator
• Neuropsychological complications of hypoprolactinemia
• New insight into interference-free and highly sensitive dopamine electroanalysis
• No unfavorable effects on the menstruation recovery of early postoperative hypoprolactinemia after transsphenoidal surgery in patients with lactotroph pituitary neuroendocrine tumor
• Nonalcoholic Fatty Liver Disease, Bone and Muscle Quality in Prolactinoma: A Pilot Study
• Normal intellectual ability and hyperprolactinemia as unique clinical manifestations of congenital hypothyroidism: A case report and review of hypotheses
• Overcoming therapy resistance in prolactinomas: from perspectives to real clinical practice
• Pegvisomant and pasireotide in PRL and GH co-secreting vs GH-secreting Pit-NETs
• Pegvisomant or pasirotide in PRL and GH co-secreting vs GH-secreting Pit-NETs
• Pharmacogenomics and non-genetic factors affecting drug response in autism spectrum disorder in Thai and other populations: current evidence and future implications
• Pituitary gland metastasis of breast cancer presenting as diabetes insipidus: A case report
• Pituitary Hyperplasia Due to Longstanding Primary Hypothyroidism: A Case Report and Comprehensive Review of the Literature
• Prevalence of endocrine disorders in 304 premenopausal women referred with oligomenorrhoea
• Prevalence of Endocrinopathies in a Cohort of Patients with Rett Syndrome: A Two-Center Observational Study
• Prognostic factors for surgical treatment of prolactin-secreting pituitary adenomas
• Prolactin-secreting pituitary adenomas: male-specific differences in pathogenesis, clinical presentation and treatment
• Prolactinoma and Adenomyosis - More than Meets the Eye: A Case Report
• Prolactinomas: Preconception and During Pregnancy
• Protective Effect of Hyperprolactinemia on Oxidative Stress in Patients with Psychotic Disorder on Atypical Antipsychotics Risperidone and Paliperidone: A Cross-Sectional Study
• Quetiapine and Valproic Acid-induced Central Hypothyroidism in a Patient with Autism Spectrum Disorder and Intractable Epilepsy: A Case Report
• Rare and Complicated Granulomatous Lobular Mastitis (2000-2023): A Bibliometrics Study and Visualization Analysis
• Reply to the Letter to the Editor on "Prolactin is a Key Factor for Nonalcoholic Fatty Liver Disease in Obese Children"
• Risk Assessment of Diabetes Mellitus during and after Pregnancy in Women with Prolactinomas
• Secondary vs. primary pituitary xanthogranulomas: Which yellow is more mellow?
• Sepiapterin Reductase Deficiency Misdiagnosed as Neurological Sequelae of Meningitis
• Sex differences in prolactin levels and clinical outcomes in patients with a first psychotic episode
• Sex-specific differences in the clinical profile among psychiatric patients with pulmonary Embolism: a hospital-based retrospective study
• Significance of Duodenal Prolactin Receptor Modulation by Calcium and Vitamin D in Sulpiride-Induced Hyperprolactinemia
• Study on mechanism of regulation of sex hormones in treatment of hyperprolactinemia-induced ovulatory disorder infertility with Bushen Culuan Formula
• Successful medical management of a pituitary macroadenoma with features of resistant acromegaly and hyperprolactinemia using pasireotide
• Suppressive Effects of Neuromedin U Receptor 2-Selective Peptide Agonists on Appetite and Prolactin Secretion in Mice
• The Association Between Prolactin Levels and Cognitive Function in Female Patients With Severe Mental Disorders
• The Diagnostic Value of Conventional MRI Combined With Diffusion-Weighted Imaging in Microprolactinomas
• The relationship between low prolactin and type 2 diabetes
• The research trend of hyperprolactinemia from 2011 to 2023 was analyzed by bibliometrics
• The Role of Artificial Intelligence in Endocrine Management: Assessing ChatGPT's Responses to Prolactinoma Queries
• Tolerability and safety outcomes of first-line oral second-generation antipsychotics in patients with schizophrenia
• Treatment of antipsychotic-induced hyperprolactinemia: an umbrella review of systematic reviews and meta-analyses
• Treatment of hyperprolactinemia in women: A Position Statement from the Brazilian Federation of Gynecology and Obstetrics Associations (Febrasgo) and the Brazilian Society of Endocrinology and Metabolism (SBEM)
• Treatment of sexual dysfunction induced by hyperprolactinemia accompanied by reduced luteinizing hormone levels: A case report
• Unveiling the spectrum: A cross-sectional exploration of hirsutism causes in women
• Value of cannulated prolactin testing in identifying true hyperprolactinaemia in females of reproductive age